Because the effects of ROS are determined by the balance between production and detoxification of ROS in cells, it is still unclear whether PPARγ agonists could regulate the levels of detoxifying enzymes, such as superoxide dismutase, catalase, and glutathione peroxidase, in HCC cells. Here, CAT is linked to hepatocellular carcinoma.